Symbion Health (ASX:SY1) Return-on-Tangible-Equity : Negative Tangible Equity% (As of Jun. 2007)

Symbion Health Return-on-Tangible-Equity Chart

Symbion Health Annual Data
	Trend	Jun98	Jun99	Jun00	Jun01	Jun02	Jun03	Jun04	Jun05	Jun06	Jun07
Return-on-Tangible-Equity		Get a 7-Day Free Trial					-29.19	11.10	18.69	-15.61	Negative Tangible Equity

Symbion Health Semi-Annual Data
	Jun95	Jun96	Jun97	Jun98	Jun99	Jun00	Jun01	Jun02	Jun03	Jun04	Jun05	Jun06	Jun07
Return-on-Tangible-Equity	Get a 7-Day Free Trial								-29.19	11.10	18.69	-15.61	Negative Tangible Equity

Competitive Comparison of Symbion Health's Return-on-Tangible-Equity

For the Healthcare Plans subindustry, Symbion Health's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Symbion Health's Return-on-Tangible-Equity Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Symbion Health's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Symbion Health's Return-on-Tangible-Equity falls into.

Symbion Health Return-on-Tangible-Equity Calculation

Symbion Health's annualized Return-on-Tangible-Equity for the fiscal year that ended in Jun. 2007 is calculated as

Symbion Health's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2007 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is one times the annual (Jun. 2007) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.

Symbion Health  (ASX:SY1) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.

Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.

Symbion Health Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Symbion Health's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Symbion Health (ASX:SY1) Business Description